GlassScriptPhysician profile
Kelly Wesselhoff
NPI 1013444066
$8,646.33
in general payments reported to CMS, 2019-2025
30 companies · $2,185 in 2025
The $2,185 reported for 2025 was more than what 95% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $328 · 2022: $885 · 2023: $2,290 · 2024: $2,959 · 2025: $2,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,433.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,440.06 | 2022-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Talisman |
| Abiomed | $1,569.95 | 2022-2025 | Impella |
| Amgen INC. | $730.70 | 2023-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $497.32 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $425.47 | 2021-2025 | Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $408.55 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $326.20 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $275.49 | 2023-2024 | Xarelto |
| Endotronix, INC. | $226.46 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Alnylam Pharmaceuticals INC. | $207.23 | 2023-2025 | Amvuttra |
| Actelion Pharmaceuticals US, INC. | $198.57 | 2023-2024 | Opsumit, Uptravi |
| Pfizer INC. | $196.35 | 2021-2025 | |
| Kestra Medical Technology Services, INC. | $172.51 | 2023-2025 | Assure Wcd |
| Medtronic, INC. | $157.31 | 2021 | |
| Sanofi-Aventis U.S. LLC | $149.99 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $143.95 | 2023-2025 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $138.33 | 2023-2024 | Camzyos |
| Irhythm Technologies, INC. | $52.10 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Atricure, INC. | $42.57 | 2023 | |
| Impulse Dynamics (USA) INC. | $36.49 | 2023 | Optimizer |
| Boston Scientific Corporation | $34.51 | 2025 | Cds - Mct/Cem Monitoring |
| Teleflex LLC | $33.42 | 2024 | Quikclot |
| Kiniksa Pharmaceuticals International, Plc | $32.53 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $30.97 | 2021 | |
| Itamar Medical INC | $29.49 | 2023-2024 | Watchpatone |
| Cvrx, INC. | $24.50 | 2024 | Barostim Neo System |
| Kiniksa Pharmaceuticals, LTD. | $19.69 | 2023 | Arcalyst |
| Philips North America LLC | $16.00 | 2023 | |
| Scpharmaceuticals INC. | $15.82 | 2023 | |
| Lemaitre Vascular, INC. | $13.80 | 2023 | Cardiocel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Wesselhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.